B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NCSTN

MOLECULAR TARGET

nicastrin

UniProt: Q92542NCBI Gene: 233851 compounds

NCSTN (nicastrin) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NCSTN

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Dihydroergocristine0.691

About NCSTN as a Drug Target

NCSTN (nicastrin) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented NCSTN interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NCSTN inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.